Medicare Enrolled
Dr. Wissam Hoyek, MD
Interventional Cardiology · Staten Island, NY
Practice pattern: Electrophysiology & Device
— Practice focused on heart rhythm disorders and cardiac device management
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hoyek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hoyek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hoyek
Dr. Wissam Hoyek is an interventional cardiology specialist in Staten Island, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hoyek performed 3,389 Medicare services across 2,362 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hoyek received a total of $253,767 from 52 pharmaceutical and/or device companies across 1112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hoyek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in NY
$253,767 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,389
Medicare services
Top 15% in NY for interventional cardiology
2,362
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~178 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,081 | $14 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
809 | $82 | $218 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
331 | $183 | $499 |
| Heart muscle strain imaging | 322 | $35 | $95 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
150 | $114 | $303 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
92 | $215 | $577 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
90 | $102 | $275 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
86 | $161 | $469 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
61 | $8 | $15 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
44 | $206 | $669 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
42 | $211 | $675 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
42 | $155 | $768 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $150 | $397 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
31 | $169 | $477 |
| Cardiac catheterization | 29 | $202 | $1,725 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
28 | $73 | $200 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
28 | $218 | $547 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
14 | $116 | $329 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $120 | $504 |
| Autonomic nervous system testing with tilt This test evaluates the function of the sympathetic and parasympathetic nervous systems. It involves monitoring the patient for at least five minutes while they are tilted. |
13 | $142 | $368 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
12 | $23 | $61 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
12 | $810 | $2,183 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
11 | $64 | $209 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
11 | $116 | $312 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.4% high complexity
21.0% medium
67.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$253,767
Total received (2018-2024)
Avg $36,252/year across 7 years
Top 3% in NY for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,112
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$233,942 (92.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,202 (7.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$624 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,979
2023
$17,132
2022
$18,779
2021
$26,479
2020
$23,683
2019
$71,147
2018
$86,566
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$3,953
Merck Sharp & Dohme LLC
$3,691
Novartis Pharmaceuticals Corporation
$425
Boston Scientific Corporation
$306
AstraZeneca Pharmaceuticals LP
$212
E.R. Squibb & Sons, L.L.C.
$183
Intra-Sana Laboratories
$173
Boehringer Ingelheim Pharmaceuticals, Inc.
$136
Abbott Laboratories
$130
Novo Nordisk Inc
$125
Medtronic, Inc.
$117
Philips North America LLC
$108
PFIZER INC.
$80
SCPHARMACEUTICALS INC.
$66
Kiniksa Pharmaceuticals International, plc
$48
Janssen Pharmaceuticals, Inc
$45
Bayer Healthcare Pharmaceuticals Inc.
$45
Lexicon Pharmaceuticals, Inc.
$45
Esperion Therapeutics, Inc.
$44
Tactile Systems Technology Inc
$24
ATRICURE, INC.
$23
Top 3 companies account for 80.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$63,148
Amgen Inc.
$47,416
Novartis Pharmaceuticals Corporation
$41,492
Amarin Pharma Inc.
$20,427
Esperion Therapeutics, Inc.
$19,077
Kowa Pharmaceuticals America, Inc.
$12,817
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$11,181
Merck Sharp & Dohme LLC
$10,652
PFIZER INC.
$7,896
E.R. Squibb & Sons, L.L.C.
$5,559
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,634
Abbott Laboratories
$3,240
Medtronic, Inc.
$1,124
AstraZeneca Pharmaceuticals LP
$915
Boston Scientific Corporation
$643
CVRx, Inc.
$563
GlaxoSmithKline, LLC.
$474
VASCULAR SOLUTIONS, INC.
$420
Ra Medical Systems, Inc.
$367
Philips Electronics North America Corporation
$286
Cardiovascular Systems Inc.
$280
Intra-Sana Laboratories
$173
Edwards Lifesciences Corporation
$154
Medtronic Vascular, Inc.
$140
Saranas, Inc.
$137
Novo Nordisk Inc
$125
ABIOMED
$123
Bayer HealthCare Pharmaceuticals Inc.
$122
Philips North America LLC
$108
BIOTRONIK INC.
$107
Gilead Sciences, Inc.
$100
Venclose Inc.
$83
SCPHARMACEUTICALS INC.
$66
Biohaven Pharmaceutical Holding Company Ltd.
$65
Amryt Pharma Holdings Ltd
$64
Lilly USA, LLC
$57
Allergan Inc.
$55
HeartFlow, Inc.
$50
Kiniksa Pharmaceuticals International, plc
$48
Bayer Healthcare Pharmaceuticals Inc.
$45
Lexicon Pharmaceuticals, Inc.
$45
Bardy Diagnostics, Inc.
$40
Tactile Systems Technology Inc
$39
Vifor Pharma, Inc.
$36
ARBOR PHARMACEUTICALS, INC.
$31
Medtronic MiniMed, Inc.
$29
Kiniksa Pharmaceuticals, Ltd.
$27
ATRICURE, INC.
$23
G Medical Diagnostic Services, Inc.
$22
Kestra Medical Technology Services, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$13
Arrow International, Inc.
$8
Top 3 companies account for 59.9% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (6571) Eagle Eye · (6575) Coronary Undivided · (BQ9) Coronary IVUS · AIRSUPRA · ASSURITY · AVALUS · AVEIR · Adempas · Arcalyst · Assure WCD · BASAGLAR · BREZTRI · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CATHETER - CLOSUREFAST · CG FUTURE · CHANTIX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Catheter - GuideLiner · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DABRA · DAKLINZA · DRAGONFLY OPSTAR · Diamondback Coronary · Dragonfly OCT · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVRSF · Edarbi · Edora 8 DR-T · FARXIGA · FASENRA · FFRct · FLEXITOUCH · FUROSCIX · Flexitouch Plus · GALLANT · GLYCATE · HeartMate 3 Left Ventricular Dev · INSPIRIS RESILIA AORTIC VALVE · Impella · JARDIANCE · JUXTAPID · Juxtapid · Kerendia · LEQVIO · LifeVest · Livalo · MITRACLIP · MitraClip System · NEXLETOL · NEXLIZET · NURTEC ODT · ONYX FRONTIER · PRADAXA · PRALUENT · PressureWire FFR · RELTONE 200 MG · RESOLUTE ONYX · Repatha · Resolute · SUPERA · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · VERQUVO · VIAGRA · VYNDAQEL · Varithena Administration Pack · Vascepa · Veltassa · WATCHMAN · XARELTO · Xience Sierra Coronary Stent · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for interventional cardiology in NY.
Geographic Context
Interventional cardiologists within 10 mi
164
Per 100K population
33.3
County median income
$98,290
Nearest hospital
STATEN ISLAND UNIVERSITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hoyek is an electrophysiology & device specialist, with above-average Medicare volume (top 15% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hoyek experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Hoyek performed 1,081 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hoyek receive payments from pharmaceutical companies?
Yes. Dr. Hoyek received a total of $253,767 from 52 companies across 1,112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hoyek's costs compare to other interventional cardiologists in Staten Island?
Dr. Hoyek's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hoyek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Staten Island
Browse interventional cardiologists in Staten Island ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in NY
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in NY
Which NY interventional cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology